Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$28.82 - $77.35 $14,410 - $38,675
-500 Closed
0 $0
Q1 2022

Apr 15, 2022

BUY
$48.25 - $100.49 $4,825 - $10,049
100 Added 25.0%
500 $33,000
Q1 2020

Apr 23, 2020

SELL
$59.04 - $88.81 $5,904 - $8,881
-100 Reduced 20.0%
400 $28,000
Q4 2019

Feb 03, 2020

BUY
$59.49 - $82.78 $29,745 - $41,390
500 New
500 $39,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Atticus Wealth Management, LLC Portfolio

Follow Atticus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atticus Wealth Management, LLC with notifications on news.